XML 49 R39.htm IDEA: XBRL DOCUMENT v3.23.2
Stock Options - SARs (Details) - USD ($)
3 Months Ended 6 Months Ended
Apr. 18, 2022
Jun. 30, 2023
Jun. 30, 2023
SARs      
Outstanding beginning balance     489,250
Forfeited     (12,250)
Outstanding ending balance   477,000 477,000
Weighted average exercise price      
Weighted average exercise price, beginning balance (per share)     $ 39.35
Weighted average exercise price, forfeited (per share)     39.33
Weighted average exercise price, ending balance (per share)   $ 39.35 $ 39.35
Aggregate intrinsic value      
Aggregate intrinsic value   $ 2,313,000 $ 2,313,000
Weighted average remaining contractual term (years)     9 years 6 months
Stock Appreciation Rights (SARs)      
Aggregate intrinsic value      
Fair Value of Liability   976,000 $ 976,000
Stock-based compensation expense   264,000 166,000
Stock-based compensation cost, unrecognized   $ 5,820,000 $ 5,820,000
Stock-based compensation cost, unrecognized, weighted-average period of recognition     9 years 6 months
Stock Appreciation Rights (SARs) | SAR Plan      
Stock option details      
Shares available for future grants 750,000    
Maximum exercisable period for granted share-based compensation 10 years    
Number of rights issued     502,250
Vesting period 8 years    
SARs      
Granted     502,250